News | March 10, 2026
Avio Smart teams up with Huwel Lifesciences to roll out next-gen molecular diagnostics in India
Huwel’s diagnostic solutions leverage open RT-PCR system
Huwel’s diagnostic solutions leverage open RT-PCR system
Pfizer’s anti-infectives portfolio includes both established therapies for moderate to severe infections and newer, clinically robust antimicrobial treatments
Approval marks Venus Remedies’ first anti-infective marketing authorization in Indonesia and enables the country’s first generic entry for this critical antibiotic combination
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
The accelerated review covers WCK 5222 for multiple critical infections
The approval of Nuzolvence (zoliflodacin) follows a collaborative development effort with the Global Antibiotic Research and Development Partnership
The reform is set to modernise how medicines are developed, authorised, and made available across the EU
The cobas Mass Spec solution Ionify reagent portfolio now covers therapeutic drug monitoring for immunosuppressants and antibiotics
Captured microbes are then neutralized on engineered microbicidal surfaces
Surgical site infections and antimicrobial resistance remain major challenges globally
Subscribe To Our Newsletter & Stay Updated
